138 related articles for article (PubMed ID: 16075925)
21. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
Prabhakar BS; Bahn RS; Smith TJ
Endocr Rev; 2003 Dec; 24(6):802-35. PubMed ID: 14671007
[TBL] [Abstract][Full Text] [Related]
22. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis and treatment of the ophthalmopathy associated with Graves' disease.
Velkeniers B; Salu P
Bull Soc Belge Ophtalmol; 1992; 245():9-14. PubMed ID: 1344754
[TBL] [Abstract][Full Text] [Related]
24. Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein.
Bahn RS; Gorman CA; Johnson CM; Smith TJ
J Clin Endocrinol Metab; 1989 Sep; 69(3):622-8. PubMed ID: 2760173
[TBL] [Abstract][Full Text] [Related]
25. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
Bahn RS
Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
[TBL] [Abstract][Full Text] [Related]
26. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
27. Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens.
Otto EA; Ochs K; Hansen C; Wall JR; Kahaly GJ
J Clin Endocrinol Metab; 1996 Aug; 81(8):3045-50. PubMed ID: 8768872
[TBL] [Abstract][Full Text] [Related]
28. Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy.
Bahn RS; Gorman CA; Woloschak GE; David CS; Johnson PM; Johnson CM
J Clin Endocrinol Metab; 1987 Oct; 65(4):665-70. PubMed ID: 3654911
[TBL] [Abstract][Full Text] [Related]
29. Graves' orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study.
Leo M; Maggi F; Dottore GR; Casini G; Mazzetti P; Pistello M; Sellari-Franceschini S; Nardi M; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2017 May; 40(5):499-503. PubMed ID: 27987077
[TBL] [Abstract][Full Text] [Related]
30. Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review.
Shanmuganathan T; Girgis C; Lahooti H; Champion B; Wall JR
Clin Ophthalmol; 2015; 9():2271-6. PubMed ID: 26664042
[TBL] [Abstract][Full Text] [Related]
31. The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation.
Smith TJ
Autoimmunity; 2003; 36(6-7):409-15. PubMed ID: 14669949
[TBL] [Abstract][Full Text] [Related]
32. The fibroblast is the target cell in the connective tissue manifestations of Graves' disease.
Bahn RS
Int Arch Allergy Immunol; 1995 Mar; 106(3):213-8. PubMed ID: 7888783
[TBL] [Abstract][Full Text] [Related]
33. Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy.
Rotondo Dottore G; Leo M; Casini G; Latrofa F; Cestari L; Sellari-Franceschini S; Nardi M; Vitti P; Marcocci C; Marinò M
Thyroid; 2017 Feb; 27(2):271-278. PubMed ID: 27824294
[TBL] [Abstract][Full Text] [Related]
34. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
[TBL] [Abstract][Full Text] [Related]
35. Thyroglobulin release-stimulating activity in immunoglobulin G from patients with Graves' disease studied by human thyroid cells in vitro.
Fukue Y; Uchimura H; Mitsuhashi T; Okano S; Kanaji Y; Takaku F
J Clin Endocrinol Metab; 1987 Feb; 64(2):261-5. PubMed ID: 2878936
[TBL] [Abstract][Full Text] [Related]
36. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
van Steensel L; Paridaens D; Dingjan GM; van Daele PL; van Hagen PM; Kuijpers RW; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1002-7. PubMed ID: 19797221
[TBL] [Abstract][Full Text] [Related]
37. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy.
Tan GH; Dutton CM; Bahn RS
J Clin Endocrinol Metab; 1996 Feb; 81(2):449-52. PubMed ID: 8636247
[TBL] [Abstract][Full Text] [Related]
40. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.
Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA
Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
